Advances in organ-on-chip for drug transporter study: Key insights and hurdles
Abstract
Membrane transporters play a central role in the absorption, distribution, metabolism, and elimination of drugs. Beyond drug handling, these transporters regulate the transport of endogenous metabolites, contributing to physiological homeostasis. Their activity is regulated not only by intrinsic cellular mechanisms but also by signals from distant organs. Understanding these processes is crucial for accurately predicting both local and systemic pharmacokinetics, as transporter function influences drug concentrations and effects at target tissues and throughout the organism. However, most current in vitro models do not recapitulate interorgan interactions or the dynamic regulation of transporter function. Microphysiological systems, particularly organ-on-chip, offer a promising approach to studying transporter biology in a more integrated and physiologically relevant context. This review provides an overview of the development and application of organ-on-chip technologies to investigate drug transporters and their regulation. Although significant technical progress has been made, these systems often remain focused on engineering or industrial goals, with limited impact on fundamental biological questions. Moreover, the high degree of customization and widespread use of homemade organ-on-chip models, with diverse materials, geometries, and cell sources, have created substantial barriers to reproducibility and cross-laboratory comparison. We here assess the current state of the field and identify gaps in modeling transporter regulation and interorgan communication. We also explore the potential of organ-on-chip to advance our understanding of systemic pharmacology. This review aims to reposition organ-on-chip platforms not only as technological demonstrators but also as experimental systems capable of generating new biological insights into transporter function and organ crosstalk. SIGNIFICANCE STATEMENT: Membrane transporters are central regulators of drug disposition and systemic homeostasis, yet their interorgan regulation remains poorly captured by conventional models. This review highlights how organ-on-chip technologies can bridge this gap, enabling mechanistic investigation of transporter function and advancing predictive, human-relevant pharmacology.
Related
- Human organ chip models recapitulate FRC-driven high endothelial venule differentiation, immune recruitment, and cancer-induced disruption
- Quantifying Assay Confidence in Barrier Organ-on-Chip Systems: A Monte Carlo Assay-Readiness Framework for Detecting Modest Permeability Shifts
- Microphysiological Systems in Cancer Research: Advancing Immunotherapy through Tumor Microenvironment-Integrated Organ-On-Chip Models
- Towards Quantitative In Vitro Modelling of Focused Ultrasound-mediated Blood-Brain Barrier Opening using an Ultrasound-transparent Organ-on-Chip Device
- Molecular insights into Acinetobacter calcoaceticus JK40-mediated zinc availability and transporter gene modulation in rice
BibTeX
@article{petit2026advances,
title = {{Advances in organ-on-chip for drug transporter study: Key insights and hurdles}},
author = {Isy Petit and Jean-Sébastien Bernard and Quentin Faucher and Dorian Chastagner and Hélène Arnion and Florent Di Meo and Nicolas Védrenne},
journal = {Drug Metabolism and Disposition},
year = {2026},
month = oct,
doi = {10.1016/j.dmd.2026.100312},
url = {https://hal.science/hal-05793487v1},
note = {CC BY-NC-ND},
}
RIS
TY - JOUR
TI - Advances in organ-on-chip for drug transporter study: Key insights and hurdles
AU - Isy Petit
AU - Jean-Sébastien Bernard
AU - Quentin Faucher
AU - Dorian Chastagner
AU - Hélène Arnion
AU - Florent Di Meo
AU - Nicolas Védrenne
PY - 2026
DA - 2026/10/12
JO - Drug Metabolism and Disposition
DO - 10.1016/j.dmd.2026.100312
UR - https://hal.science/hal-05793487v1
AB - Membrane transporters play a central role in the absorption, distribution, metabolism, and elimination of drugs. Beyond drug handling, these transporters regulate the transport of endogenous metabolites, contributing to physiological homeostasis. Their activity is regulated not only by intrinsic cellular mechanisms but also by signals from distant organs. Understanding these processes is crucial for accurately predicting both local and systemic pharmacokinetics, as transporter function influences drug concentrations and effects at target tissues and throughout the organism. However, most current in vitro models do not recapitulate interorgan interactions or the dynamic regulation of transporter function. Microphysiological systems, particularly organ-on-chip, offer a promising approach to studying transporter biology in a more integrated and physiologically relevant context. This review provides an overview of the development and application of organ-on-chip technologies to investigate drug transporters and their regulation. Although significant technical progress has been made, these systems often remain focused on engineering or industrial goals, with limited impact on fundamental biological questions. Moreover, the high degree of customization and widespread use of homemade organ-on-chip models, with diverse materials, geometries, and cell sources, have created substantial barriers to reproducibility and cross-laboratory comparison. We here assess the current state of the field and identify gaps in modeling transporter regulation and interorgan communication. We also explore the potential of organ-on-chip to advance our understanding of systemic pharmacology. This review aims to reposition organ-on-chip platforms not only as technological demonstrators but also as experimental systems capable of generating new biological insights into transporter function and organ crosstalk. SIGNIFICANCE STATEMENT: Membrane transporters are central regulators of drug disposition and systemic homeostasis, yet their interorgan regulation remains poorly captured by conventional models. This review highlights how organ-on-chip technologies can bridge this gap, enabling mechanistic investigation of transporter function and advancing predictive, human-relevant pharmacology.
SN - 0090-9556
SN - 1521-009X
ER -